This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dion's Weekly ETF Winners and Losers

NEW YORK ( TheStreet) -- Here are this week's winners and losers.


iPath S&P 500 VIX Short Term Futures ETN (VXX) (VXX) 8%

The market's rally at the end of the week caused VXX to give back a portion of its gains. The losses were not enough to offset the ETN's strength entirely. On the contrary, it still managed to score a spot near the top of this week's winners list.

Heading into next week, VXX is in the process of testing its 50-day moving average. This is the first time this level has been visited since its initial ascension in early August. Many of the same factors that have sparked investor concerns in recent months remain in play. It will be interesting to see if VXX can remain buoyed here.

iShares Dow Jones U.S. Home Construction Index Fund (ITB) 7.4%

A strong batch of data and an optimistic report from the National Association of Homebuilders helped to propel homebuilder-related ETFs higher. ITB and the SPDR S&P Homebuilder ETF (XHB) have enjoyed impressive action over the course of the month.

Real estate will again be in focus next week as investors anticipate the release of new and pending home sales reports.

Although homebuilders appear promising, investors should continue to steer clear. The housing market remains muddled in uncertainty. Those looking for a safer bet on this sector should turn to a REIT-focused fund like the iShares Cohen & Steers Realty Majors Fund (ICF).

iShares MSCI Israel Capped Investable Market Index Fund (EIS) 4.4%

The Israel ETF has had a rough couple of months. As global macroeconomic concerns have driven investors out of international markets, shares of EIS have tumbled hard. At the end of September, the fund had retreated to levels seen during the middle of 2009.

In October, however, it appears as though the nation's marketplace has found some footing.

Investors interested in venturing into EIS should exercise caution. The fund's index is dominated by two companies: Teva Pharmaceuticals (TEVA) and Israel Chemical. Together, these two holdings represent over one-third of its index. Their respective performances will do much of the driving here.


Market Vectors Junior Gold Miners ETF (GDXJ) -7.7%

Despite its reputation as a safe haven destination, gold prices have struggled in recent weeks. The metal's shaky action, combined with investor hesitance toward market-correlated sectors, has weighed on gold miner stocks.

Given its spurt of peculiar action recently, it will be interesting to see what is in store for gold in the days ahead.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
GDXJ $19.14 2.63%
TAO $20.92 -0.76%
VXX $19.03 0.69%
EIS $50.85 0.33%
ITB $28.57 1.13%


Chart of I:DJI
DOW 17,812.19 +19.51 0.11%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs